13F-HR filed by Bronte Capital Management Pty Ltd.
Bronte Capital Management Pty Ltd. filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-10, with 29 holding rows worth $1,516,046,000.
- Accession
- 0001471085-22-000002
- Filer
- CIK 1471085
- Filed
- 2022-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 29 entries on the cover page, a total value of $1,516,046,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,516,046,000 with VALUE read as thousands by filing date, 13F file number 028-19143. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| iShares Russell 2000 ETF | 464287655 | SHS | 177,900 | $399,441,000 | thousands by filing date | call |
| ISHARES TR | 464287648 | RUS 2000 GRW ETF | 703,900 | $206,278,000 | thousands by filing date | call |
| Alphabet Inc. Reg. Shares A | 02079K305 | COM | 48,892 | $141,642,000 | thousands by filing date | |
| Berkshire Hathaway Inc | 084670702 | COM | 415,836 | $124,335,000 | thousands by filing date | |
| HERBALIFE LTD | G4412G101 | COM SHS | 2,755,572 | $112,786,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 948,200 | $106,160,000 | thousands by filing date | call |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 130,460 | $82,388,000 | thousands by filing date | |
| INTERACTIVE BROKERS GROUP INC COM CL A | 45841N107 | Stock | 856,785 | $68,046,000 | thousands by filing date | |
| CORTEVA INC COM | 22052L104 | Stock | 882,257 | $41,713,000 | thousands by filing date | |
| Visa Inc | 92826C839 | COM | 191,345 | $41,466,000 | thousands by filing date | |
| BANK OF NY MELLON CORP COM | 064058100 | Stock | 481,240 | $27,950,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 5,700 | $27,167,000 | thousands by filing date | call |
| STATE STR CORP COM | 857477103 | Stock | 264,779 | $24,624,000 | thousands by filing date | |
| GRAHAM HLDGS CO COM CL B | 384637104 | Stock | 29,595 | $18,640,000 | thousands by filing date | |
| Alphabet Inc. Reg. Shares C | 02079K107 | COM | 5,798 | $16,777,000 | thousands by filing date | |
| Altria Group Inc | 02209S103 | COM | 268,018 | $12,701,000 | thousands by filing date | |
| GENERAL MILLS INC COM | 370334104 | Stock | 168,374 | $11,345,000 | thousands by filing date | |
| Philip Morris International Inc. | 718172109 | COM | 117,045 | $11,119,000 | thousands by filing date | |
| SOTERA HEALTH CO | 83601L102 | COM | 396,667 | $9,342,000 | thousands by filing date | |
| BEYOND MEAT INC | 08862E109 | COM | 100,000 | $6,516,000 | thousands by filing date | put |
| Mondelez International,Inc. Class A | 609207105 | COM | 88,471 | $5,867,000 | thousands by filing date | |
| BATH & BODY WORKS INC COM | 070830104 | Stock | 58,984 | $4,116,000 | thousands by filing date | |
| SOCIEDAD QUIMICA Y MINERA DE C | 833635105 | SPON ADR SER B | 75,627 | $3,814,000 | thousands by filing date | |
| ENPRO INC | 29355X107 | COM | 29,599 | $3,258,000 | thousands by filing date | |
| NEWMONT CORP | 651639106 | COM | 48,779 | $3,025,000 | thousands by filing date | |
| Merrimack Pharmaceuticals Inc | 590328209 | Common / Ordinary Stock | 537,584 | $2,102,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 6,702 | $1,728,000 | thousands by filing date | |
| BEYOND MEAT INC | 08862E109 | COM | 14,873 | $969,000 | thousands by filing date | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 157,216 | $731,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001471085-22-000002 | this filing | 2022-02-10 | acceptance time not in the bulk data set |